Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).

H J Wanebo; J Lee; B A Burtness; J A Ridge; M Ghebremichael; S A Spencer; D Psyrri; E Pectasides; D Rimm; F R Rosen; M R Hancock; K A Tolba; A A Forastiere

首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).

【24h】

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).

机译：诱导西妥昔单抗，紫杉醇和卡铂治疗，然后用西妥昔单抗，紫杉醇和卡铂进行化学放射治疗III / IV期头颈部鳞癌：ECOG-ACRIN II期临床试验（E2303）。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

NCT 00089297.

机译：NCT 00089297。

著录项

来源
《Annals of oncology: official journal of the European Society for Medical Oncology》 |2014年第10期|共6页
作者
H J Wanebo; J Lee; B A Burtness; J A Ridge; M Ghebremichael; S A Spencer; D Psyrri; E Pectasides; D Rimm; F R Rosen; M R Hancock; K A Tolba; A A Forastiere;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. 不能手术的Ⅲ期非小细胞肺癌患者每周紫杉醇和卡铂并同步放疗的诱导化疗：一个Ⅱ期研究结果 [J] . Hend Ahmed El-Hadaad, Hanan Ahmed Wahba, Eman Toson 中德临床肿瘤学杂志（英文版） . 2013,第002期
2. Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303). [J] . H J Wanebo, J Lee, B A Burtness, Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第10期

机译：诱导西妥昔单抗，紫杉醇和卡铂治疗，然后用西妥昔单抗，紫杉醇和卡铂进行化学放射治疗III / IV期头颈部鳞癌：ECOG-ACRIN II期临床试验（E2303）。
3. A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC). [J] . Socinski MA, Saleh MN, Trent DF Annals of oncology: official journal of the European Society for Medical Oncology . 2009,第6期

机译：一项卡铂/紫杉醇/西妥昔单抗的两种剂量方案治疗IIIB / IV期非小细胞肺癌（NSCLC）的随机II期试验。
4. A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC) [J] . M. A. Socinski1* M. N. Saleh2 D. F. Trent3 T. W. Dobbs4 L. M. Zehngebot5 M. A. Levine6 R. Bordoni2 and P. J. Stella7 Annals of Oncology . 2009,第6期

机译：卡铂/紫杉醇/西妥昔单抗两种剂量方案治疗IIIB / IV期非小细胞肺癌（NSCLC）的随机II期试验
5. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
6. Induction cetuximab paclitaxel and carboplatin followed by chemoradiation with cetuximab paclitaxel and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303) [O] . H. J. Wanebo, J. Lee, B. A. Burtness, -1

机译：诱导西妥昔单抗紫杉醇和卡铂治疗然后用西妥昔单抗紫杉醇和卡铂进行化学放射治疗III / IV期头颈部鳞癌：ECOG-ACRIN II期临床试验（E2303）
7. Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin Vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial) [O] . Georgios Tsakonas, Lena Specht, Claus Andrup Kristensen, 2020

机译：随机阶段II与西汀昔单抗与5-FU和顺铂或Carboplatin与Cetuximab一起研究。西妥昔单抗与紫杉醇和卡铂联合治疗头部和颈部复发或转移性鳞状细胞癌的患者（Cetmet试验）

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).

摘要

著录项

相似文献

相关主题

期刊订阅